Fig. 1From: Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practiceProportion of patient with a viral load (VL) < 50 copies/mL after 12-months and 24-months follow-up. PI protease inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitorBack to article page